Hosted on MSN
University Health EVS team honored with Invisible Hero Award for stopping spread of C diff
SAN ANTONIO - A group of frontline hospital workers who often go unseen in day-to-day patient care was recognized Friday at University Health San Antonio. LIV Process, a biotechnology research company ...
DEAR DR. ROACH: I read your recent column about a person who was refusing antibiotics due to a fear of a Clostridioides difficile (C. diff) recurrence. I am interested in your thoughts regarding ...
A new imaging approach used microscopic glowing tags to reveal gene activity in individual C. diff cells in gut tissue samples from infected mice. Here, a resulting image shows a round cross-section ...
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile - commonly known as C. diff - are a serious and persistent problem for patients and ...
Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...
EAR DR. ROACH: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...
Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...
IgA nephropathy, first described in 1968 by Berger and Hinglais, 1 is the most common form of primary glomerulonephritis. For decades, IgA nephropathy was considered to have a relatively good ...
Gillum is associate vice president of compliance and research administration and adjunct faculty in the School of Public Health at the University of Nevada, Reno. Franz is a visiting research fellow ...
Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of the Cambridge, Massachusetts–based biotech’s workforce ...
Dear Dr. Roach: I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and off. I initially spoke to my general physician, and he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results